Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Olsson

Showing results (571-580 of 632) with videos related to

Pageof 64
Sort By:
JAMA|April 13, 2001
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trialG G Schwartz, A G Olsson, M D Ezekowitz, et al.
Atherosclerosis|November 9, 2004
Locating Ath8, a locus for murine atherosclerosis susceptibility and testing several of its candidate genes in mice and humansRon Korstanje, Per Eriksson, Ann Samnegård, et al.
Atherosclerosis|March 31, 2009
Congestive heart failure is associated with lipoprotein components in statin-treated patients with coronary heart disease Insights from the Incremental Decrease in End points Through Aggressive Lipid Lowering Trial (IDEAL)Ingar Holme, Timo E Strandberg, Ole Faergeman, et al.
Annals of Medicine|January 23, 2009
Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease In End-points Through Aggressive Lipid-lowering Trial (IDEAL)Ingar Holme, Nilo B Cater, Ole Faergeman, et al.
Advances in Experimental Medicine and Biology|January 1, 1978
The Edinburgh-Stockholm study of coronary heart disease risk factors: a summaryR L Logan, R A Riemersma, M F Oliver, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1994
Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cellsC I Smith, B Baskin, P Humire-Greiff, et al.
Journal of Internal Medicine|February 10, 2010
Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trialI Holme, R Fayyad, O Faergeman, et al.
Circulation|September 25, 2002
Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudyDavid D Waters, Gregory G Schwartz, Anders G Olsson, et al.
European Journal of Preventive Cardiology|February 25, 2025
Mental health status and quality-of-life after an acute myocardial infarction with non-obstructive coronary arteries or takotsubo syndrome: A systematic reviewPhilip Leissner, Erik M G Olsson, Elisabet Rondung, et al.
Placenta|March 2, 2011
Perfusion of human placenta with hemoglobin introduces preeclampsia-like injuries that are prevented by α1-microglobulinK May, L Rosenlöf, M G Olsson, et al.
Pageof 64

Showing results (571-580 of 632) with videos related to

Sort By:
Pageof 64
JAMA|April 13, 2001
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trialG G Schwartz, A G Olsson, M D Ezekowitz, et al.
Atherosclerosis|November 9, 2004
Locating Ath8, a locus for murine atherosclerosis susceptibility and testing several of its candidate genes in mice and humansRon Korstanje, Per Eriksson, Ann Samnegård, et al.
Atherosclerosis|March 31, 2009
Congestive heart failure is associated with lipoprotein components in statin-treated patients with coronary heart disease Insights from the Incremental Decrease in End points Through Aggressive Lipid Lowering Trial (IDEAL)Ingar Holme, Timo E Strandberg, Ole Faergeman, et al.
Annals of Medicine|January 23, 2009
Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease In End-points Through Aggressive Lipid-lowering Trial (IDEAL)Ingar Holme, Nilo B Cater, Ole Faergeman, et al.
Advances in Experimental Medicine and Biology|January 1, 1978
The Edinburgh-Stockholm study of coronary heart disease risk factors: a summaryR L Logan, R A Riemersma, M F Oliver, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1994
Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cellsC I Smith, B Baskin, P Humire-Greiff, et al.
Journal of Internal Medicine|February 10, 2010
Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trialI Holme, R Fayyad, O Faergeman, et al.
Circulation|September 25, 2002
Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudyDavid D Waters, Gregory G Schwartz, Anders G Olsson, et al.
European Journal of Preventive Cardiology|February 25, 2025
Mental health status and quality-of-life after an acute myocardial infarction with non-obstructive coronary arteries or takotsubo syndrome: A systematic reviewPhilip Leissner, Erik M G Olsson, Elisabet Rondung, et al.
Placenta|March 2, 2011
Perfusion of human placenta with hemoglobin introduces preeclampsia-like injuries that are prevented by α1-microglobulinK May, L Rosenlöf, M G Olsson, et al.
Pageof 64